TEZRULY (TERAZOSIN HYDROCHLORIDE) — FDA Approval NDA218139 (NOVITIUM PHARMA)
TEZRULY (TERAZOSIN HYDROCHLORIDE) — FDA Approval NDA218139 (NOVITIUM PHARMA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: TEZRULY; Active ingredients: TERAZOSIN HYDROCHLORIDE; Application number: NDA218139.
| Brand name | TEZRULY |
|---|---|
| Active ingredients | TERAZOSIN HYDROCHLORIDE |
| Application number | NDA218139 |
| Sponsor | NOVITIUM PHARMA |
| Dosage form | SOLUTION |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20240729 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →